Delivery Order SPE2DB22D1202-SPE2DB25FUJT2
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,553.82 firm fixed-price delivery order is for the supply of 4562781064 - CLOBAZAM 10 MG TABLET 100S, with a completion date of November 13, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,592.48 firm fixed-price delivery order covers the supply of 4,567,316,869 units of the medication CLOBAZAM 10 MG TABLET 100S. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,616.82 Firm Fixed Price Delivery Order contract is for the supply of CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product, with a completion date of February 13, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
- This federal contract award, valued at $1,555.93, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product, to support military healthcare programs. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,302.58 firm fixed-price delivery order is for the supply of 4566848238 - CLOBAZAM 10 MG TABLET 100S, with a completion date of January 7, 2025. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as the...
- This federal contract award, valued at $8,044.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4562592259 - CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product, with an ultimate completion date of October 26, 2023. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not associated with a set-aside program....
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,222.75 Firm Fixed Price Delivery Order contract is for the supply of 4563528898 - CLOBAZAM 10 MG TABLET 100S. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,555.93 firm fixed-price delivery order is for the supply of CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product. The contract has a performance period through June 25, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $7,233.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of 4567361463 - CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product. The contract has a period of performance through February 25, 2025 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,275.60 fixed-price delivery order is for the supply of 4563636579 CLOBAZAM 10 MG TABLET 100S, with a completion date of February 13, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FUJT2Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,681.02 firm fixed-price delivery order is for the supply of 4566449615 - CLOBAZAM 10 MG TABLET 100S, with a period of performance through November 18, 2024. This award is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This delivery order award demonstrates AmerisourceBergen's role as a key vendor for federal healthcare programs, particularly within the Department of Defense and Veterans Affairs medical systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.7k | 11/15/24 |